EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.
29.07.2014
- Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...
16.01.2014
- Moving Away - Many would argue that the future of pharmaceutical growth in the coming years will come from emerging markets; U.S. pharma sales have been sluggish recently with a...
14.12.2012
- The active pharmaceutical ingredients (API) market in the Americas was worth a staggering $46 billion in 2011, with North America accounting for over 88% of it. But thanks to...
31.05.2010
- Ubichem, a provider of chemistry services to the drug development sector, through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection...
18.05.2010
- Pros And Cons - European pharmaceutical manufacturing and API production has experienced a shift of a significant proportion of total production to Asia in recent years, driven...
